BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 6.46 Million CAD | 18.35% |
| 2022 | 5.45 Million CAD | -13.11% |
| 2021 | 6.28 Million CAD | 65.51% |
| 2020 | 3.79 Million CAD | -13.14% |
| 2019 | 4.36 Million CAD | -23.42% |
| 2018 | 5.7 Million CAD | 9.59% |
| 2017 | 5.2 Million CAD | 20.81% |
| 2016 | 4.3 Million CAD | 14.47% |
| 2015 | 3.76 Million CAD | 19.37% |
| 2014 | 3.15 Million CAD | 63.59% |
| 2013 | 1.92 Million CAD | 25.09% |
| 2012 | 1.54 Million CAD | 266.64% |
| 2011 | 420.39 Thousand CAD | 705.97% |
| 2010 | 52.16 Thousand CAD | 120.02% |
| 2009 | -260.55 Thousand CAD | 9.49% |
| 2008 | -287.89 Thousand CAD | -128.5% |
| 2007 | -125.99 Thousand CAD | -132.88% |
| 2006 | 383.14 Thousand CAD | -24.17% |
| 2005 | 505.25 Thousand CAD | 261.6% |
| 2004 | -312.65 Thousand CAD | 24.64% |
| 2003 | -414.87 Thousand CAD | -11.64% |
| 2002 | -371.62 Thousand CAD | -147.61% |
| 2001 | 780.5 Thousand CAD | 292.49% |
| 2000 | -405.46 Thousand CAD | 18.91% |
| 1999 | -500 Thousand CAD | 54.55% |
| 1998 | -1.1 Million CAD | -83.33% |
| 1997 | -600 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.58 Million CAD | -10.65% |
| 2024 Q1 | 1.76 Million CAD | 21.91% |
| 2023 Q4 | 1.45 Million CAD | -38.29% |
| 2023 Q1 | 1.17 Million CAD | -2.02% |
| 2023 Q3 | 2.35 Million CAD | 58.5% |
| 2023 FY | 6.46 Million CAD | 18.35% |
| 2023 Q2 | 1.48 Million CAD | 26.2% |
| 2022 Q2 | 1.21 Million CAD | -23.3% |
| 2022 Q1 | 1.58 Million CAD | -15.44% |
| 2022 Q3 | 1.45 Million CAD | 19.31% |
| 2022 Q4 | 1.19 Million CAD | -17.45% |
| 2022 FY | 5.45 Million CAD | -13.11% |
| 2021 Q2 | 1.01 Million CAD | -38.83% |
| 2021 Q3 | 1.72 Million CAD | 69.08% |
| 2021 Q4 | 1.87 Million CAD | 9.09% |
| 2021 Q1 | 1.66 Million CAD | 150.02% |
| 2021 FY | 6.28 Million CAD | 65.51% |
| 2020 FY | 3.79 Million CAD | -13.14% |
| 2020 Q3 | 955.9 Thousand CAD | 32.36% |
| 2020 Q1 | 1.45 Million CAD | 24.29% |
| 2020 Q4 | 665.7 Thousand CAD | -30.36% |
| 2020 Q2 | 722.2 Thousand CAD | -50.24% |
| 2019 Q2 | 690.84 Thousand CAD | -29.37% |
| 2019 FY | 4.36 Million CAD | -23.42% |
| 2019 Q3 | 1.53 Million CAD | 121.82% |
| 2019 Q4 | 1.16 Million CAD | -23.79% |
| 2019 Q1 | 978.18 Thousand CAD | -41.48% |
| 2018 Q4 | 1.67 Million CAD | 31.54% |
| 2018 Q2 | 1.62 Million CAD | 41.74% |
| 2018 FY | 5.7 Million CAD | 9.59% |
| 2018 Q1 | 1.14 Million CAD | -21.55% |
| 2018 Q3 | 1.27 Million CAD | -21.58% |
| 2017 Q3 | 1.29 Million CAD | -16.64% |
| 2017 FY | 5.2 Million CAD | 20.81% |
| 2017 Q4 | 1.45 Million CAD | 12.56% |
| 2017 Q2 | 1.55 Million CAD | 72.25% |
| 2017 Q1 | 901.55 Thousand CAD | -17.65% |
| 2016 Q2 | 1.01 Million CAD | 6.68% |
| 2016 Q4 | 1.09 Million CAD | -12.23% |
| 2016 Q1 | 951.85 Thousand CAD | 24.82% |
| 2016 Q3 | 1.24 Million CAD | 22.84% |
| 2016 FY | 4.3 Million CAD | 14.47% |
| 2015 Q1 | 962.71 Thousand CAD | 27.82% |
| 2015 Q2 | 851.03 Thousand CAD | -11.6% |
| 2015 FY | 3.76 Million CAD | 19.37% |
| 2015 Q4 | 762.6 Thousand CAD | -35.84% |
| 2015 Q3 | 1.18 Million CAD | 39.66% |
| 2014 Q4 | 753.19 Thousand CAD | -24.73% |
| 2014 Q3 | 1 Million CAD | 12.58% |
| 2014 Q2 | 888.8 Thousand CAD | 73.79% |
| 2014 Q1 | 511.42 Thousand CAD | -7.94% |
| 2014 FY | 3.15 Million CAD | 63.59% |
| 2013 Q1 | 344.41 Thousand CAD | -31.59% |
| 2013 Q2 | 418.32 Thousand CAD | 21.46% |
| 2013 Q3 | 609.74 Thousand CAD | 45.76% |
| 2013 Q4 | 555.54 Thousand CAD | -8.89% |
| 2013 FY | 1.92 Million CAD | 25.09% |
| 2012 Q4 | 503.43 Thousand CAD | 17.83% |
| 2012 Q3 | 427.26 Thousand CAD | 26.62% |
| 2012 Q2 | 337.43 Thousand CAD | 23.52% |
| 2012 Q1 | 273.18 Thousand CAD | 318.87% |
| 2012 FY | 1.54 Million CAD | 266.64% |
| 2011 Q1 | -886.00 CAD | -101.05% |
| 2011 FY | 420.39 Thousand CAD | 705.97% |
| 2011 Q4 | 65.22 Thousand CAD | -72.36% |
| 2011 Q3 | 235.99 Thousand CAD | 108.45% |
| 2011 Q2 | 113.21 Thousand CAD | 12878.1% |
| 2010 Q1 | -50.9 Thousand CAD | 70.13% |
| 2010 Q4 | 84.14 Thousand CAD | -33.94% |
| 2010 Q3 | 127.38 Thousand CAD | 217.44% |
| 2010 Q2 | -108.46 Thousand CAD | -113.07% |
| 2010 FY | 52.16 Thousand CAD | 120.02% |
| 2009 Q1 | -168.19 Thousand CAD | 0.79% |
| 2009 Q4 | -170.41 Thousand CAD | -220.04% |
| 2009 Q2 | -63.91 Thousand CAD | 62.0% |
| 2009 Q3 | 141.96 Thousand CAD | 322.12% |
| 2009 FY | -260.55 Thousand CAD | 9.49% |
| 2008 FY | -287.89 Thousand CAD | -128.5% |
| 2008 Q4 | -169.52 Thousand CAD | -442.61% |
| 2008 Q3 | 49.48 Thousand CAD | 152.77% |
| 2008 Q2 | -93.77 Thousand CAD | -26.61% |
| 2008 Q1 | -74.06 Thousand CAD | 52.94% |
| 2007 Q2 | -147.95 Thousand CAD | -402.98% |
| 2007 FY | -125.99 Thousand CAD | -132.88% |
| 2007 Q1 | -29.41 Thousand CAD | -133.95% |
| 2007 Q4 | -157.4 Thousand CAD | -175.39% |
| 2007 Q3 | 208.78 Thousand CAD | 241.11% |
| 2006 Q1 | 39.77 Thousand CAD | 149.5% |
| 2006 FY | 383.14 Thousand CAD | -24.17% |
| 2006 Q4 | 86.65 Thousand CAD | -71.46% |
| 2006 Q3 | 303.59 Thousand CAD | 747.74% |
| 2006 Q2 | -46.86 Thousand CAD | -217.85% |
| 2005 Q4 | -80.34 Thousand CAD | -235.37% |
| 2005 Q3 | 59.35 Thousand CAD | 634.97% |
| 2005 FY | 505.25 Thousand CAD | 261.6% |
| 2005 Q1 | 537.34 Thousand CAD | 468.0% |
| 2005 Q2 | -11.09 Thousand CAD | -102.06% |
| 2004 Q4 | -146.01 Thousand CAD | -368.91% |
| 2004 Q1 | -66.87 Thousand CAD | 66.52% |
| 2004 Q2 | -68.62 Thousand CAD | -2.61% |
| 2004 FY | -312.65 Thousand CAD | 24.64% |
| 2004 Q3 | -31.14 Thousand CAD | 54.62% |
| 2003 Q1 | -185.77 Thousand CAD | -29.11% |
| 2003 FY | -414.87 Thousand CAD | -11.64% |
| 2003 Q4 | -199.76 Thousand CAD | -563.2% |
| 2003 Q3 | 43.12 Thousand CAD | 159.51% |
| 2003 Q2 | -72.46 Thousand CAD | 60.99% |
| 2002 Q1 | -177.72 Thousand CAD | -116.49% |
| 2002 Q2 | -122.45 Thousand CAD | 31.1% |
| 2002 Q4 | -143.89 Thousand CAD | -298.62% |
| 2002 FY | -371.62 Thousand CAD | -147.61% |
| 2002 Q3 | 72.44 Thousand CAD | 159.16% |
| 2001 Q3 | 5310.00 CAD | 103.62% |
| 2001 Q1 | -155.49 Thousand CAD | -46.08% |
| 2001 FY | 780.5 Thousand CAD | 292.49% |
| 2001 Q4 | 1.07 Million CAD | 20192.09% |
| 2001 Q2 | -146.82 Thousand CAD | 5.57% |
| 2000 Q4 | -106.44 Thousand CAD | -991.91% |
| 2000 Q3 | 11.93 Thousand CAD | 111.93% |
| 2000 Q2 | -100 Thousand CAD | 50.0% |
| 2000 Q1 | -200 Thousand CAD | 33.33% |
| 2000 FY | -405.46 Thousand CAD | 18.91% |
| 1999 Q3 | 100 Thousand CAD | 200.0% |
| 1999 Q4 | -300 Thousand CAD | -400.0% |
| 1999 Q1 | -200 Thousand CAD | 0.0% |
| 1999 FY | -500 Thousand CAD | 54.55% |
| 1999 Q2 | -100 Thousand CAD | 50.0% |
| 1998 Q1 | -100 Thousand CAD | 0.0% |
| 1998 Q4 | -200 Thousand CAD | 0.0% |
| 1998 FY | -1.1 Million CAD | -83.33% |
| 1998 Q3 | -200 Thousand CAD | 66.67% |
| 1998 Q2 | -600 Thousand CAD | -500.0% |
| 1997 Q4 | - CAD | 100.0% |
| 1997 Q3 | -300 Thousand CAD | 0.0% |
| 1997 FY | -600 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | 317.9% |
| CanadaBis Capital Inc. | 4.44 Million CAD | -45.351% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | 464.979% |
| Delivra Health Brands Inc. | 876 Thousand CAD | -637.457% |
| Entourage Health Corp. | -46.16 Million CAD | 113.993% |
| Lifeist Wellness Inc. | -14.12 Million CAD | 145.733% |
| Cannara Biotech Inc. | 6.94 Million CAD | 6.987% |
| Medicure Inc. | -922 Thousand CAD | 800.665% |
| PharmaCielo Ltd. | -16.29 Million CAD | 139.638% |
| Rubicon Organics Inc. | -1.82 Million CAD | 454.264% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | 561.613% |